News
LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% Ballerup, Denmark, 15 May, 2025 - In Q1, LEO Pharma continued its robust growth, driven by ...
Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025HDP-101 demonstrated complete response in one female patient from cohort 5R&D Webinar to be ...
CNX Therapeutics to accelerate European growth strategy with Inflexion's £2.3bn Continuation FundLondon, May 15th, 2025 – CNX Therapeutics Limited (“CNX Therapeutics”), a European specialty ...
Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback